Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATR |
Variant | E1229* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATR E1229* results in a premature truncation of the Atr protein at amino acid 1229 of 2644 (UniProt.org). Due to the loss of the PI3K/PI4K domain and the FATC domain (UniProt.org), E1229* is predicted to lead to a loss of Atr protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATR mutant ATR inact mut ATR E1229* |
Transcript | NM_001184.4 |
gDNA | chr3:g.142538522C>A |
cDNA | c.3685G>T |
Protein | p.E1229* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001184 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_047448363.1 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_011512926 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_011512924.2 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_047448364.1 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_047448360.1 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_011512924 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
NM_001184.4 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
NM_001184.3 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_011512924.1 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_047448362.1 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
XM_047448361.1 | chr3:g.142538522C>A | c.3685G>T | p.E1229* | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|